a method for increasing circulating and/or intracellular levels of glutathione includes administering an effective amount of S-acetyl-glutathione (SAG) in the form of delayed-release composition to raise the circulating levels of glutathione to achieve clinically beneficial effects
InterpretationAcross domains, most findings are preclinical
Nucleic Acids Res 46 , 21852196 (2018)
autophagy is the next line of compensation active when the UPS cannot degrade proteins, especially during senescence (Shimura et al., 2004
therefore, we performed co-IP and found that ACTL6A HR mutant did not bind to NRF2 (Fig
These additionally internalized receptors are for the most part dimerized with MC3R (Schellekens et al., 2013), suggesting that dimerization with MC3R may not only lead to reduced efficiency of GHSR1a signaling, but also to reduced surface expression of the receptor